All Comments by Randall Bateman
Go to another page:
- 1
- 2
- Better Diagnosis with Blood Test Detecting Only Tau Made in Brain
- Amyloid Alone—Any Amyloid—Raises P-Tau in Mice
- Single Synapse Mass Spec Snags CD47 as Alzheimer’s Resilience Factor
- Plasma Aβ—First Sign of AD, But Tough to Measure Prospectively?
- In Side-by-Side Test of 8 Blood Aβ Assays, Mass Spec Shines
- Earliest of Them All: Blood P-Tau231 Assay Flags Pre-Amyloid Alzheimer’s
- Plasma p-Tau217 Set to Transform Alzheimer’s Diagnostics
- In DIAN-TU, Gantenerumab Brings Down Tau. By a Lot. Open Extension Planned
- ‘Reports of My Death Are Greatly Exaggerated.’ Signed, Aducanumab
- BAN2401 Removes Brain Amyloid, Possibly Slows Cognitive Decline
- ABBY: A phase 2 randomized trial of crenezumab in mild to moderate Alzheimer disease.
- Merck Axes Verubecestat for Prodromal AD, Researchers Say ‘Go Earlier’
- BACE Block Nips New Plaques in the Bud, Old Ones Keep Growing
- Closing in on a Blood Test for Alzheimer’s?
- Lilliputian Effect Size Fells Phase 3 Trial of Solanezumab, Leaving Its Future Uncertain